Home Costly hepatitis drug Sovaldi rattles industry
 

Keywords :   


Costly hepatitis drug Sovaldi rattles industry

2014-03-02 05:54:49| Biotech - Topix.net

When the Food and Drug Administration approved a medication called Sovaldi in December, it was hailed as a breakthrough in the fight against hepatitis C, a blood-borne disease that affects 3.2 million Americans and kills more people in the U.S. annually than AIDS.

Tags: industry drug costly hepatitis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
26.06LG and Blacknut provide cloud video games through webOS
26.06Universal UK resort to open 365 days a year
26.06Steelwork closures' ripple effect on town's wages
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
More »